Serum Endocan Levels and Gestational Diabetes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-03

Study Completion Date

2022-05-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In diabetic patients, serum endocan level has been significantly increased in patients and the levels on the long-term complications are correlated. Based on the Iinformation obtained from these studies, it can be said that there is a strong association between diabetes and serum endocan levels.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Trimester Sequential Estimation of Serum Zonulin as a Predictor of Gestational Diabetes Mellitus

NCT06336512

Gestational Diabetes

COMPLETED NA

Predictability of Gestational Diabetes Mellitus in First and Second Trimester

NCT02035059

Pregnancy Gestational Diabetes Mellitus

COMPLETED

Weight Changes During and After Pregnancy in Women With Gestational Diabetes

NCT02388958

Gestational Diabetes Mellitus

COMPLETED

Comparison of the Detection Rates of 50 Gr-100 Gr OGTT and 75 Gr OGTT That Require Medical Treatment of GDM

NCT04585204

Gestational Diabetes Glucose Intolerance During Pregnancy

RECRUITING NA

Biomarkers for Early Screening of Gestational Diabetes Mellitus

NCT05142020

Gestatiaonl Diabetes Mellitus Early Pregnancy

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It has been shown that endocan level of plasental tissue in gestational diabtes patients is significantly increased when looking at the same week compared with plasenta tissue samples of helathy pregnancy. From the information obtained from these studies, it can be said that there is a strong association between diabetes mellitus and serum endocan levels. investigators aimed to determine the relationship between serum endocan levels and gestational diabetes in the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gestational Diabetes Endocan

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with Gestational Diabetes

pregnant women who are at 24-26 weeks of gestational age with positive oral glucose tolerance screening test.

Group Type OTHER

Serum Endocan Levels

Intervention Type DIAGNOSTIC_TEST

Detection of Serum Endocan Levels and detection of possible diagnostic association with gestational diabetes

Healty Pregnants

pregnant women who are at 24-26 weeks of gestational age with normal oral glucose tolerance screening test.

Group Type OTHER

Serum Endocan Levels

Intervention Type DIAGNOSTIC_TEST

Detection of Serum Endocan Levels and detection of possible diagnostic association with gestational diabetes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.